Bain Capital Specialty Finance (NYSE: BCSF) delivered Q2 FY2026 net investment income of $28.6 million ($0.44 per share), up 4.4% sequentially from Q1's $0.42 but down 6.4% from the year-ago $0.47, with the four-line P&L walk finishing at a $14.1 million net increase in net assets because realized and unrealized losses totaled $14.6 million. Net asset value per share fell to $16.65 from $16.86 at March 31 and $17.23 at year-end 2025, a 3.4% sequential decline that the company attributes to credit and unrealized marks rather than operating deterioration, but the operational signal is the asset coverage ratio compression to 171.0% from 175.9% at year-end 2025, the tightest cushion against the 150% regulatory floor in recent memory, and the non-accrual portfolio that more than doubled to 3.2% of amortized cost from 1.5% at year-end 2025, with the count of non-accrual issuers dropping from six to four even as the dollar exposure expanded. The market is reading the print as soft: at $12.55 on August 14, 2026, the shares trade at 0.75x NAV and yield 13.4% on the $0.42 quarterly base dividend, a 24.6% discount to NAV that is wider than the externally-managed BDC peer median and that the bears read as the market pricing in a credit cycle that has not yet bottomed. The next test is whether Q3 2026 (10-Q expected early November 2026) can hold NII per share above the $0.42 base distribution while the credit migration moderates, the question the 25-point asset coverage compression is asking.